(Q46518719)

22 December 2017

title

Psychological insulin resistance: the patient perspective (English)

1 reference

22 December 2017

1 reference

1 reference

William Polonsky

1

1 reference

22 December 2017

publication date

1 July 2007

1 reference

22 December 2017

The Science of Diabetes Self-Management and Care

published in

1 reference

22 December 2017

volume

33 Suppl 7

1 reference

22 December 2017

page(s)

241S-244S

1 reference

22 December 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Impact of dosage frequency on patient compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

The burden of treatment failure in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Timely addition of insulin to oral therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Self-management support for insulin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721707305701

21 January 2018

Identifiers

DOI

10.1177/0145721707305701

1 reference

22 December 2017

PubMed ID

17656740

1 reference

22 December 2017